focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInspecs Group Regulatory News (SPEC)

Share Price Information for Inspecs Group (SPEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 71.00
Bid: 70.00
Ask: 72.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.857%)
Open: 70.50
High: 71.00
Low: 71.00
Prev. Close: 71.00
SPEC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of AGM

11 Aug 2022 15:31

RNS Number : 7632V
Inspecs Group PLC
11 August 2022
 

11 August 2022

Inspecs Group plc

("Inspecs" the "Company" or "the Group")

Result of AGM

 

Inspecs Group plc, a leading designer, manufacturer and distributor of eyewear frames, announces that at the Annual General Meeting held earlier today, all resolutions were duly passed.

 

Resolution

For

Against

Withheld

Total votes cast

Number of

votes

%

Number of votes

%

Number of votes

 

1.

Ordinary resolution to receive and adopt the Company's annual accounts and reports

74,283,217

86.36%

11,730,789

13.64%

2,918,304

88,932,310

2.

Ordinary resolution to declare a final dividend

88,932,210

100.00%

100

0.00%

0

88,932,310

3.

Ordinary resolution to re-elect Lord MacLaurin as a director of the Company.

70,273,568

90.69%

7,211,334

9.31%

11,447,408

88,932,310

4.

Ordinary resolution to re-elect Robin Totterman as a director of the Company.

88,932,065

100.00%

245

0.00%

0

88,932,310

5.

 

Ordinary resolution to re-elect Christopher Kay as a director of the Company.

88,235,979

99.22%

696,231

0.78%

100

88,932,310

6.

 

 

Ordinary resolution to re-elect Christopher Hancock as a director of the Company.

67,757,305

82.13%

14,739,869

17.87%

6,435,136

88,932,310

7.

 

 

Ordinary resolution to re-elect Richard Peck as a director of the Company.

68,126,562

82.58%

14,370,612

17.42%

6,435,136

88,932,310

8.

 

 

Ordinary resolution to re-elect Angela Farrugia as a director of the Company.

82,242,520

96.48%

3,004,273

3.52%

3,685,517

88,932,310

9.

Ordinary resolution to re-appoint Ernst & Young LLP as the Company's auditors to hold office from the conclusion of this meeting until the conclusion of the next meeting, in accordance with normal practice.

88,932,310

100.00%

0

0.00%

0

88,932,310

10.

Ordinary resolution to authorise the directors to determine the remuneration of the auditors

88,932,310

100.00%

0

0.00%

0

88,932,310

11.

 

 

Ordinary resolution to enable the Company and each of its subsidiaries to make political donations and expenditure.

87,095,027

99.33%

587,995

0.67%

1,249,288

88,932,310

12.

Ordinary resolution to authorise the directors to allot ordinary shares in the Company up to a maximum nominal amount of £338,905.08 and up to a further

maximum nominal amount of £338,905.08 where the allotment is in connection with an offer by way of a rights issue.

88,932,065

100.00%

245

0.00%

0

88,932,310

13.

Special resolution to enable the directors to allot, grant options over or otherwise dispose of equity securities for cash or sell treasury shares for cash up to a maximum aggregate nominal amount of £50,835.76 as if pre-emption rights did not apply to such allotment.

87,682,777

98.60%

1,249,283

1.40%

250

88,932,310

14.

Special Resolution to further disapply pre-emption rights in relation to acquisitions or other capital investments.

87,682,777

98.60%

1,249,283

1.40%

250

88,932,310

15.

Special resolution to authorise the Company to make market purchases of up to 10,167,153 ordinary shares (which represents approximately 10 per cent of the Company's ordinary shares (excluding treasury shares) in issue on 31 December 2021).

88,932,065

100.00%

245

0.00%

0

88,932,310

 

 

For further information please contact:

 

Inspecs Group plc

Robin Totterman (CEO)

Chris Kay (CFO)

 

via FTI Consulting

Tel: +44 (0) 20 3727 1000

Peel Hunt (Nominated Adviser and Broker)

Adrian Trimmings

Andrew Clark

Lalit Bose

 

 

Tel: +44 (0) 20 7418 8900

FTI Consulting (Financial PR)

Alex Beagley

Harriet Jackson

Alice Newlyn

 

 

Tel: +44 (0) 20 3727 1000

About Inspecs Group plc

INSPECS is a Bath-based designer, manufacturer and distributor of eyewear frames and optically advanced spectacle lenses. The Group produces a broad range of frames and lenses, covering optical, sunglasses and safety, which are either "Branded" (either under licence or under the Group's own proprietary brands), or "OEM" (including private label on behalf of retail customers and un-branded).

INSPECS aims to be the leader in eyewear solutions through its vertically-integrated business model and has adopted a three pillar growth strategy to achieve this: (i) continue to grow organically; (ii) undertake further acquisitions (and drive value through leveraging the Group's internal capabilities); and (iii) extend the Group's manufacturing capacity.

 The Group has completed a number of significant acquisitions since its IPO in February 2020. In December 2020, INSPECS acquired Eschenbach, a leading global eyewear supplier, headquartered in Nuremberg, Germany, which includes the American company Tura. This followed the acquisition of lens maker Norville in July 2020, whereby INSPECS combined two heritage brands in British optical, Savile Row frame maker, and Norville lens maker, further enhancing its vertically integrated business model. In December 2021 the Group acquired Ego Eyewear, a design and licensing company which uses third party eyewear manufacturers to produce premium fashion brands, and BoDe, a distributor of optical and sunglasses frames principally to the German market. 

INSPECS customers include global optical and non-optical retailers, global distributors and independent opticians, with its distribution network covering over 80 countries and reaching approximately 75,000 points of sale.

INSPECS has operations across the globe: with offices in the UK, Portugal, Scandinavia, the US and China (Hong Kong, Macau and Shenzhen), and manufacturing facilities in Vietnam, China, the UK and Italy. With the acquisition of Eschenbach, the Group's international reach further extends across Europe and the American markets.

 

More information is available at: https://inspecs.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGPBMITMTTBBPT
Date   Source Headline
18th Aug 20227:00 amRNSInterim Results
11th Aug 20223:31 pmRNSResult of AGM
11th Jul 20221:19 pmRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSDirector/PDMR Shareholding
1st Jul 20222:26 pmRNSDirector/PDMR Dealing
29th Jun 202212:37 pmRNSDirector/PDMR Shareholding
29th Jun 20227:00 amRNSFinal Results
24th Jun 20227:00 amRNSNotice of Final Results
7th Jun 20224:38 pmRNSHolding(s) in Company
31st May 202211:14 amRNSHolding(s) in Company
17th May 20225:41 pmRNSChange to Publication Date of Results
27th Apr 20227:00 amRNSQ1 Trading Update and Notice of Results
31st Mar 20224:17 pmRNSDirector/PDMR Share Dealing
18th Mar 202210:09 amRNSHolding(s) in Company
2nd Mar 20227:00 amRNSDirector/PDMR Share Dealing
1st Feb 20227:00 amRNSFull Year Trading Update
24th Jan 20227:00 amRNSHolding(s) in Company
11th Jan 20227:00 amRNSHolding(s) in Company
6th Jan 20227:00 amRNSAllotment of shares
24th Dec 20218:14 amRNSDirector/PDMR Share Dealing
23rd Dec 20217:00 amRNSAcquisition of Ego Eyewear
8th Dec 20217:00 amRNSAcquisition of BoDe
28th Oct 20217:00 amRNSQ3 Trading Update
20th Oct 20215:13 pmRNSHolding(s) in Company
8th Sep 20217:00 amRNSInterim Results
13th Aug 20217:00 amRNSNotice of Results
19th Jul 202111:42 amRNSResult of AGM
25th Jun 20217:00 amRNSAnnual Report and Notice of Annual General Meeting
21st Jun 20217:00 amRNSDirector/PDMR Dealing
18th Jun 20217:00 amRNSFinal Results
29th Apr 20217:00 amRNSQ1 Trading Update & Notice of Results
26th Feb 20217:00 amRNSDirector/PDMR LTIP Awards
8th Feb 20215:57 pmRNSHolding(s) in Company
29th Jan 20217:00 amRNSFull Year Trading Update
13th Jan 20218:25 amRNSHolding(s) in Company
23rd Dec 20204:21 pmRNSDirector/PDMR LTIP Awards
11th Dec 20201:05 pmRNSHolding(s) in Company
11th Dec 202012:00 pmRNSHolding(s) in Company
11th Dec 202011:58 amRNSDirector/PDMR Share Dealings
10th Dec 20203:11 pmRNSEschenbach Acquisition satisfaction of condition
7th Dec 20201:01 pmRNSResult of General Meeting
20th Nov 20207:00 amRNSPublication of Circular and Notice of GM
19th Nov 20202:05 pmRNSResult of Placing and Total Voting Rights
19th Nov 20207:00 amRNSProposed Placing
19th Nov 20207:00 amRNSProposed Acquisition of Eschenbach Holding GmbH
14th Oct 20201:53 pmRNSHolding(s) in Company
7th Oct 202012:06 pmRNSHolding(s) in Company
22nd Sep 20207:00 amRNSInterim Results
14th Sep 20207:00 amRNSNotice of Results
12th Aug 20204:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.